Transcatheter Interventions Online 2021 - On Demand

Published: 20 April 2021

  • Views:

    Views Icon 96232
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Following on from the success of 2020's inaugural edition, Transcatheter Interventions Online 2021 again brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.

 

Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2021 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.

 

Note, the live version of this session was CME accredited; this on-demand version is not.

 

Transcatheter Interventions Online 2021 was sponsored by the following companies:

 

CSI  Shockwave Medical Inc

Transcatheter Interventions Online 2021 was supported by the following educational partners:

More from this programme

Faculty Biographies

Azeem Latib

Azeem Latib

Section Head of Interventional Cardiology

Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology. Dr Latib is the Section Head and Director of Interventional Cardiology as well as the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart and Vascular Care. 

He is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

His focus is on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions. His main clinical interests include Complex Coronary Interventions, Structural Heart Disease and New Device Innovation. He has extensive clinical experience in TAVR and MitraClip, as well as expertise in novel and new devices to treat mitral and tricuspid valve disease minimally invasively without open-heart surgery.

Dr Latib is currently involved in the development of the NeoChord NeXuS Transcatheter Mitral Chordal…

View full profile
Kendra J Grubb

Kendra J Grubb

Surgical Director

Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine.

Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease.

Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.

Dr Grubb research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of…

View full profile
Holger Thiele

Holger Thiele

Professor

Dr Holger Thiele, former director and full professor in the Department of Internal Medicine/Cardiology/Angiology of the University Heart Center Lübeck at the University of Lübeck has been nominated by the faculty of the University of Leipzig as full Professor and Director of the Department of Internal Medicine/Cardiology of the Heart Center Leipzig which is affiliated with the University of Leipzig. 

View full profile
Lars Søndergaard

Lars Søndergaard

Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

View full profile
David Hildick-Smith

David Hildick-Smith

Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.

A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment. 

View full profile